Does Health Insurance Cover Wegovy? What to Know Before You Ask

Wegovy is a prescription-only injectable medicine containing semaglutide, used for weight management under clinical supervision. Because it is a prescription medicine rather than an over-the-counter product, some insurance and healthcare funding schemes do consider it for coverage — but the rules differ enormously from one country, one plan, and one individual to the next.

What insurers and funding bodies typically look at

Where coverage exists at all, it is usually conditional. Insurers and public health systems that fund weight-management medicines commonly assess factors such as:

• Documented medical need — a diagnosis such as obesity (often defined by BMI thresholds) or weight-related conditions such as type 2 diabetes or hypertension
• Prior treatment history — evidence that lifestyle interventions have been attempted
• Prescriber involvement — a formal prescription from a qualified clinician, sometimes with specialist input
• Plan-specific formularies — private insurers often publish a list of covered medicines; whether Wegovy appears on yours depends entirely on your plan

Coverage varies dramatically by country

In some countries, publicly funded healthcare systems cover Wegovy for people who meet strict clinical criteria. In others, it is available only through private prescription with no public subsidy. Private health insurance plans add another layer of variation: some explicitly exclude weight-loss medicines, others cover them with prior authorisation, and policies are changing as evidence and demand grow. If you have questions about how Wegovy works and what it is prescribed for, that background context can help you frame your conversation with an insurer.

What your prescriber can do

Your prescriber or doctor is your most important ally when seeking coverage. They can provide clinical documentation, write letters of medical necessity, and navigate the specific criteria that apply in your healthcare system. If your insurer has declined coverage, it is worth asking your prescriber whether an appeal or resubmission with additional clinical detail is possible.

If you are travelling and wondering how insurance intersects with your medication, the topic of travel insurance and GLP-1 medicines covers some of the related considerations.

While coverage questions are being resolved, staying consistent with the prescription you already have is something you can take control of right now. One of the most practical things GLP Trackr offers is dose and injection logging — every pen you use is recorded with date, dose strength, and injection site, so nothing is forgotten and nothing is accidentally wasted.

That record also has a secondary value: when you are in conversations with insurers or at appointments with your prescriber, a clear log of your adherence and your progress can support your case. GLP Trackr's doctor report feature compiles your tracked data — weight changes, logged doses, side effects — into a summary you can bring to a clinical appointment, making those conversations more efficient.

For a broader look at managing your Wegovy journey day to day, the Wegovy tracking guide brings together the most useful tools in one place. You can also explore how GLP Trackr counts and tracks what matters across your whole journey.

If you want to understand more about GLP-1 medicines generally, including tirzepatide, the Mounjaro and GLP-1 companion hub is a useful starting point.

GLP Trackr does not sell, supply, or source Wegovy or any other medicine, and cannot advise on insurance decisions or clinical eligibility. Any questions about coverage, dosing, or suitability should be directed to your prescriber, doctor, or insurer.

Start logging your doses, tracking your progress, and building the kind of consistent record that matters — download GLP Trackr free on the App Store or Google Play and try it for 7 days at no cost.